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Two novel direct SPIO labels and in vivo
MRI detection of labeled cells after acute
myocardial infarct
Riikka M Korpi1,2, Kirsi Alestalo3,4, Timo Ruuska4,
Eveliina Lammentausta1, Ronald Borra5,6,
Fredrik Yannopoulos3, Siri Lehtonen7, Jarkko T Korpi8,
Elisa Lappi-Blanco9, Vesa Anttila3, Petri Lehenkari3,4,
Tatu Juvonen3,10 and Roberto Blanco Sequieros1,11
Abstract
Background: Acute myocardial infarction (AMI) is a leading cause of morbidity and mortality worldwide. Cellular decay
due hypoxia requires rapid and validated methods for possible therapeutic cell transplantation.
Purpose: To develop direct and rapid superparamagnetic iron oxide (SPIO) cell label for a large-animal model and to
assess in vivo cell targeting by magnetic resonance imaging (MRI) in an experimental AMI model.
Material and Methods: Bone marrow mononuclear cells (BMMNCs) were labeled with SPIO particles using two novel
direct labeling methods (rotating incubation method and electroporation). Labeling, iron incorporation in cells and label
distribution, cellular viability, and proliferation were validated in vitro. An AMI porcine model was used to evaluate the
direct labeling method (rotating incubation method) by examining targeting of labeled BMMNCs using MRI and histology.
Results: Labeling (1 h) did not alter either cellular differentiation potential or viability of cells in vitro. Cellular relaxation
values at 9.4 T correlated with label concentration and MRI at 1.5 T showing 89 4% signal reduction compared with
non-labeled cells in vitro. In vivo, a high spatial correlation between MRI and histology was observed. The extent of
macroscopic pathological myocardial changes (hemorrhage) correlated with altered function detected on MRI.
Conclusion: We demonstrated two novel direct SPIO labeling methods and demonstrated the feasibility of clinical MRI
for monitoring targeting of the labeled cells in animal models of AMI.
Keywords
Magnetic resonance imaging (MRI), acute myocardial infarct (AMI), superparamagnetic iron oxide (SPIO) particles, bone
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Acute myocardial infarction (AMI) is the most
common cause of death worldwide (1) and current
therapeutic strategies aim to establish revascularization
(2). Administration of bone marrow cells has emerged
as a potential candidate for cardiac tissue repair or as a
paracrine modulator of healing after AMI in both non-
clinical (3–6) and clinical studies (7,8), though the clin-
ical results remain controversial.
In AMI tissue repair, cell transplantation has to be
administered promptly in order to minimize cellular
decay due hypoxia. Hence, rapid and validated
in vivo methods are needed for cellular labeling and
visualization of transplanted cells. Most imaging
related stem cell studies have employed bone marrow
cells due to their ease of harvest, multi-lineage potential
(9–11), immunological advantages, and potential thera-
peutic eﬀect in AMI (3–6).
Cell tracking in vivo is crucial for the development of
novel therapies that require precise targeting of the
therapeutic agent (12,13). Contrast-enhanced magnetic
resonance imaging (MRI) is the gold standard for non-
invasive evaluation of myocardial pathology. MRI is a
suitable technique for monitoring cell migration
in vivo, cell distribution after transplantation (14,15),
and for evaluating the post-transplantation regenera-
tive eﬀect in cardiac tissue (16). Among the diﬀerent
MRI contrast agents, superparamagnetic iron oxide
(SPIO) particles are low in toxicity, oﬀer a relatively
simple, inexpensive, non-invasive, and currently the
most sensitive method for detecting labeled cells at
micromolar concentrations in T2(*)-weighted
(T2(*)W) MRI (15).
In SPIO labeling, the cells are incubated with SPIO
particles inducing endocytosis of a contrast agent (17).
SPIO particles have been used in a variety of cell label-
ing AMI protocols (17) but rather few in large animals
(6,18,19). In general, the eﬀects of the label have been
fairly well described (15). However, typical cellular
labeling times of 48 h are used, thus introducing a
potential problem of reaching a clinically feasible time
margin for cell transplantation in the acute setting.
Permeabilization agents may be used to enhance cell
labeling but they are potentially toxic (20). Based on
earlier reports (21,22), we hypothesized that clinically
suﬃcient labeling of BMMCs could be achieved with-
out the use of transfection agents or prolonged expos-
ure times via receptor-mediated intake of SPIO by
using a carboxydextran-coated SPIO contrast agent
and by using either the rotating incubation method or
electroporation. Electroporation induces the intra-cel-
lular intake of SPIO particles making possible a more
rapid clinical translation. The rotating incubation
method also potentially expedites intake of label
through the motion-related interaction of label and
cells and additionally the inhibition of cell adherence
seems to increase label intake by some unknown mech-
anism, although one probably linked to increased cel-
lular stress and induced pinocytosis.
This study aimed to demonstrate two direct and fast
in vitro SPIO labeling methods for MRI and further
characterize targeting of labeled bone marrow mono-
nuclear cells (BMMNCs) in an AMI model.
Material and Methods
Animals
An animal experiment was approved by the National
Animal Experiment Board (ESLH-2007-09818/Ym-23).
Three 56–70-day-old landrace pigs were anesthetized as
previously described (23). Brieﬂy, the pigs were anesthe-
tized with ketamine hydrochloride (Pﬁzer AB,
Sollentuna, Sverige) and midazolam (Pﬁzer AB), and
balanced anesthesia was maintained with fentanyl
(Fentanyl-Hameln, Hameln, Germany), midazolam
(Pﬁzer AB), pancuronium (0.2mg/kg/h) (Hameln),
and inhaled isoﬂurane (Orion Pharma, Turku,
Finland).
Isolation and culture of cells
The bone marrow aspirate from the tibial tuberosity
was subjected to a density-gradient centrifugation
(Ficoll-Paque Plus, GE Healthcare Bio-Sciences AB,
Uppsala, Sweden) to exclude granulocytes and erythro-
cytes. Harvested BMMNCs were washed three times
with phosphate buﬀered saline (PBS) and plated.
BMMNCs were collected and expanded in culture.
SPIO labeling
After piloting various concentrations, in the in vitro
model, SPIO labeling (labeling time 1 h) was performed
using 0.1 and 0.2mg/mL concentrations of the organ-
speciﬁc MRI contrast agent that consists of SPIO par-
ticles coated with carboxydextran, (Resovist, Bayer
Healthcare, Berlin, Germany). Two labeling methods
were used: 1¼ a rotating incubation method, where
BMMNCs were incubated with the samples being
rotated continuously to prevent aggregation; and
2¼ electroporation, where BMMNCs were suspended
in a sterile electroporation cuvette and mixed with the
label and electroporated with two square wave proto-
cols (100V for duration of 10ms and 100V 5 100V
for 10ms). Subsequently, the cells in cuvettes were
transferred to ice and washed with PBS. Control
BMMNCs were incubated with basal medium without
label. Labeled BMMNCs were suspended into an agar-
ose gel (108cells/1mL).
2 Acta Radiologica Open
In the infarct model, SPIO labeling was done as pre-
viously described (6). Brieﬂy, the rotating incubation
method with 39mg/mL ferucarbotran corresponding
to 36mM iron (Resovist, Bayer Healthcare) was used.
Infarct model
An AMI was induced as previously described (23).
Brieﬂy, the circumﬂex coronary artery (CCA) was sur-
gically coiled with a removable silicone vascular loop
(Surg-I-Loop, Scanlan, St. Paul, MN, USA) for 90min.
Next, the labeled BMMNCs (108/2mL) were
transplanted randomly into ﬁve diﬀerent locations
within the territory vascularized by CCA by direct sur-
gical intramuscular injections (26-gauge needle,
depth¼ 5–10mm). After 1 h, pigs were MRI scanned
in vivo, sacriﬁced, and cardiac tissue was prepared
and ﬁxed with 10% formaldehyde. After 24 h, myocar-
dial tissue was ex vivo MRI scanned and prepared for
histology. The left ventricle was divided into 16 seg-
ments according to a standardized myocardial
segmentation scheme (24). The tissue sections (5mm)
were excised continuously through the left ventricle
along with the short axes of the left ventricle (resulting
in three sections per segment), paraﬃn embedded, and
stained with Prussian blue as previously described (25).
MRI
MRI was performed in vitro, in vivo, and ex vivo to
validate the labeling success (in vitro), to study how
well MRI images matched with histology (in vivo)
and the correlation between in vivo and ex vivo MRI.
In vitro imaging: We utilized a 9.4T Oxford NMR
vertical magnet (Oxford Instruments, Abingdon, UK),
Varian Direct Drive console (Varian Associates Inc.,
Palo Alto, CA, USA), and 1.5T MRI scanner (GE
Signa Twinspeed, GE Healthcare, Milwaukee,
WI, USA).
At 9.4T (Oxford Instruments), spectroscopic T1, T2,
and T2* relaxation times were measured using a 10mm
spectroscopy probe. T1 was calculated from peak
Fig. 1. Localization of labeled BMMNCs in infarcted myocardium. (a) Hypo-intensity caused by SPIO-labeled cell accumulation in a
short axis view (arrows) at 1.5 T. (b) Hypo-intensity caused by SPIO-labeled BMMNCs in a DE image (arrows) at 1.5 T. (c) SPIO-
labeled BMMNCs in an ex vivo T2 FSE image at 1.5 T. Intramyocardial hemorrhage in the infarcted area results in a high signal intensity
when combined with a SPIO-label-induced area of hypointensity (arrows). (d) Intramyocardial hemorrhage visible on a macroscopic
slice of the myocardial tissue. ROI-based method was used to define each segmental area; a simplified diagram of the segmental scheme
is provided to clarify the segmentation (24); this is placed on top of the figure (b). LV, left ventricle; RV, right ventricle; D, diaphragm.
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values/areas of the spectra obtained using an inversion
recovery sequence (repetition time [TR]¼ 7000ms,
echo time [TE]¼ 2ms, 11 inversion time [TI] in the
range of 5–5000ms). T2 relaxation time was measured
using a spin echo (SE) (TR¼ 7000ms and 11 TE in the
range of 2–2000ms), and T2* relaxation time using a
gradient echo (TR¼ 1000ms and seven TE in the range
of 2–40ms) sequences.
At 1.5 T (GE Healthcare), TI SE (TR¼ 500ms,
TE¼ 13ms, ﬁeld of view [FOV]¼ 200, ﬂip angle
[FA]¼ 90, number of excitations [NEX]¼ 1, slice
thickness/interval¼ 3/1.5mm, and acquisition time
[AT]¼ 5min 44 s), T2 fast spin echo (FSE)
(TR¼ 5400ms, TE¼ 96ms, FOV¼ 200mm,
FA¼ 90, NEX¼ 1, slice thickness/interval¼ 3/1mm,
AT¼ 3min 47 s), and T2 ﬂuid-attenuated inversion
recovery (FLAIR) (TR¼ 8802ms, TE¼ 133ms,
FOV¼ 200mm, FA¼ 90, NEX¼ 1, slice thickness/
interval¼ 3/1.5mm, AT¼ 3min 31 s) sequences were
acquired using a four-channel cardiac coil.
In vivo imaging: A 1.5T scanner (GE Healthcare), a
four-channel cardiac coil, and combined ECG and
respiratory gating simulating free-breathing were used.
Fiesta 2DCINE imageswere acquired in the vertical long
axis, horizontal long axis, and short axis orientations
(TR¼ 4.2ms, TE¼ 1.8ms, matrix size¼ 256 256mm,
view size¼ 805 340mm, FOV¼ 340mm, slice thick-
ness¼ 8–11mm). In the short axis orientation, 20 cardiac
phases were reconstructed and 30 dynamic images
acquired per slice location (the locations covered the
left ventricle). A 0.2mmol/kg gadopentetate dimeglu-
mine (Magnevist, Bayer Healthcare) was injected via
the left subclavian vein just prior to (T1, multishot, gra-
dient-echo planar inversion-recovery) the perfusion
sequence (TR¼ 8 ms, TE¼ 1.2ms, matrix
size¼ 256 256mm, FOV¼ 340mm, slice thick-
ness¼ 11mm (3–5 slices). The (segmented inversion
Fig. 2. Quantitative analyses of cell amount in the segments vascularized by CCA. The relative change in signal intensity (signal
intensity loss on MRI in each segment caused by SPIO labeled BMMNCs) (a) and surface area ratio (amount of labeled BMMNCs per
segment on histology) (b) were compared. The graph shows individual relative change values (open circles, n¼ 1; open squares, n¼ 1;
and x-symbol, n¼ 1) of the measured infracted segments.
Table 1. Spatial and visual cell-amount grading correspondence
of SPIO-labeled BMMNCs.* A standardized cardiac segmentation
scheme based on the coronary vascular territories (23) was used








1 5 2 2 2
6 2 2 2
11 2 2 2
12 2 2 2
16 0 – –
2 5 0 0 0
6 2 2 2
11 0 0 0
12 0 0 0
16 0 – –
3 5 0 0 0
6 2 2 2
11 0 0 0
12 0 0 0
16 0 – –
*0¼ no cells/label, 1¼ a few BMMNCs/slight signal intensity change, 2¼ a
large amount of BMMNCs/moderate or strong signal intensity change.
–, excluded from analyses.
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recovery fast gradient echo) delayed enhancement (DE)
sequence (TR¼ 6.8ms, TE¼ 3.2ms, matrix
size¼ 256 256mm, FOV¼ 340mm, slice thick-
ness¼ 10mm, TI¼ 200–150ms) was performed 10min
after contrast agent injection.
Ex vivo imaging: At 1.5 T (GE Healthcare), a T2*
(TE¼ 15ms, TR¼ 660ms, matrix size¼ 256 256mm,
FOV¼ 140mm, slice thickness¼ 3mm), and T2 FSE
(TE¼ 86.5ms, TR¼ 5400ms, matrix size¼ 256 x
256mm, FOV¼ 140mm) sequences were used.
Imaging analyses: In vitro, in vivo, and ex vivo meas-
urements were performed by one investigator trained in
radiology and by a radiologist in consensus. The car-
diac ejection fraction was measured from 2D CINE
images using in-house software (GE advantage work-
station AW4.2 (V5.2), GE Healthcare). The amount of
myocardium infarcted was evaluated from the 2D
CINE (short axis) and DE images (in vivo) and from
T2* and T2 FSE images (ex vivo). The cell label visu-
alization was evaluated from 2D CINE (short axis)
images (in vivo) and from T2 FSE images (ex vivo).
The standardized segmentation scheme was used to
identify segmental areas in each slice (24). The extent
of AMI was recorded as a number of segments aﬀected.
The change in segmental signal intensity caused by the
iron label was qualitatively assessed using a three-scale
grading: 0¼no change; 1¼ slight; 2¼moderate/strong
signal intensity change. Quantitative signal changes in
myocardium were assessed using the septal, non-
aﬀected myocardium as reference. The relative percent-
age change of signal intensity loss caused by the iron
label in each segment was quantitatively calculated
from the 2D CINE sequences by using a region of inter-
est (ROI)-based method and by using an open-source
viewer software (Osirix v.6.5, Pixmeo, Bernex,
Switzerland). The ROI was placed to cover the entire
segment and repeated on each slice within the segment
during systolic and diastolic phases. The mean value of
the segment was used for correlation analysis with hist-
ology. The segmental division placed on one slice is
presented on Fig. 1. Perfusion and DE sequences
were included alongside the 2D CINE sequences to
broadly survey label detection and to minimize the pos-
sible evaluation problems due to the label artifacts. The
altered perfusion was recorded segmentally from perfu-
sion sequences. Of the ﬁve segments; 5, 6, 11, 12, 16,
Fig. 3. Number, localization, and morphology of BMMNCs in the myocardium. The number of BMMNCs (arrows) in the myocardium
was qualitatively evaluated as: 0¼ no cells, 1¼ a few cells (a), or 3¼ a large amount of cells (b). The BMMNCs mainly localized in slit-
like spaces within myocyte bundles or inside vessels or remained in aggregates. (c) Single elongated and flattened cells were situated
along the capillary endothelial cells and myocytes in a parallel fashion (arrow). (d) Single cells were also detected among the myocytes
(arrow). Prussian blue staining. Scale bar¼ 20mm.
Korpi et al. 5
vascularized by CCA, the segment most apex, number
16, was excluded from the MRI analysis due to prob-
lems in distinguishing the segment volume in MRI.
In vitro, relaxation times acquired at 9.4T were
ﬁtted with exponential relaxation equations using an
in-house script (MATLAB, Mathworks Inc., Natick,
MA, USA) and assuming mono-exponential decay.
Signal intensity in 1.5 T MRI was analyzed by using
an open-source viewer software (Osirix v.6.5,
Pixmeo). An ROI with a surface of 0.5 cm2 was manu-
ally drawn on each sample and control specimen in
order to quantitatively characterize the signal intensity
change due to the SPIO label. The signal intensities of
labeled specimen were reported as percentage (%) of
signal intensities of controls.
Histological analysis
Histological measurements were performed by an
investigator trained in histology and a pathologist in
consensus. The eﬀect of SPIO labeling on cellular
proliferation rate was assessed in vitro by analyzing
cultured control cells and labeled BMMNCs with the
(3 -(4,5-dimethylthiazol-2-yl)-2,5 -)diphenyltetrazolium
bromide assay (Tetrazole, Sigma-Aldrich, St. Louis,
MO, USA). MTT absorbance of the cells was measured
1–7 days after labeling by spectrophotometry.
Labeled BMMNCs in the myocardium were ana-
lyzed according to the color intensity, shape, and size.
The following three-scale classiﬁcation was used to
assess the number of the BMMNCs in the sections
within the segments: 0¼ no BMMNCs; 1¼ a few
BMMNCs; and 2¼ a large amount of BMMNCs
(Table 1). In the ﬁnal data analysis, the data of each
segment was combined so that the grading 1 in more
than one section within the segment resulted in a total
grade 2.
The scored segments were further quantitatively ana-
lyzed by counting the percentage of the surface area
covered by labeled cells in each slice by using MCID
software (3.0) (Image Analysis Software Solutions for
Life Sciences, Interfocus Imaging Ltd., Linton, UK)
Fig. 4. In vitro measurements of BMMNCs. (a) Peak relaxation measurements at 9.4 T, (b) T1W SE, T2W FSE, and T2W FLAIR
images at 1.5 T and (c) relative signal intensity measurements of cells at 1.5 T with the following labeling methods: 1¼ control;
2¼ 0.1 mg Fe electroporation (100 V, 10 ms); 3¼ 0.2 mg Fe electroporation 100 V 5 10 ms; 4¼ rotating incubation method with
0.1 mg Fe/mL; and 5¼ rotating incubation method with 0.2 mg Fe/mL. (d) Proliferation (viability) as measured by MTT absorbance of
cells 1–7 days after labeling. The statistically significant difference (< 0.05) is indicated with *¼ P< 0.001. ctrl, control; ep, electro-
poration; roll, rotating incubation method.
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and 20magniﬁcation. For comparison to the quanti-
tative MRI analysis, the mean percentage of labeled
cells in a segment was used (Fig. 2).
Statistical analysis
In vitro data are presented as mean standard devi-
ation. Statistical signiﬁcance was calculated with
Student’s t-test or one-way analysis of variance
(ANOVA) using Origin 8.5 (OriginLab, Northampton,
MA, USA).
Results
In the qualitative in vivo MRI analyses, an intramural
area of signal loss throughout the whole CINE
sequence cardiac cycle was determined to reﬂect the
presence of SPIO-labeled cells and was detected in
one to four of the ﬁve segments supplied by the CCA
in each animal (Fig. 1) corresponding to histology
(Table 1). The signal loss was also present in ex vivo
MRI images (Fig. 1). There was 100% concurrence
between the qualitative MRI and histological grading
(Table 1).
In the quantitative in vivo MRI analyses, 24–64%
signal intensity loss was detected in the SPIO- contain-
ing segments. In the segments where no label was
detected on histology, the measured signal intensity
change varied from 1% loss to 3% increase. In hist-
ology, in the segments containing BMMNCs, the per-
centage of the surface area covered by BMMNCs was
in the range of 0.002–0.927%. The relative change
values are presented in Fig. 2.
The mean ejection fraction was 51.9 5%. Delayed
enhancement, abnormal perfusion, and abnormal myo-
cardial kinetics indicating AMI were detected in the
four segments supplied by the CCA.
In the histological analysis, the majority of
BMMNCs displayed no changes in morphology
but some had become elongated and ﬂattened
and were localized in a parallel fashion along capil-
lary endothelial cells or myocytes as shown in Fig. 3.
All the cells adhering to the plastic surface displayed
signiﬁcant intracellular iron granules after 1 h of
labeling.
In vitro MRI analyses revealed changed relaxation
values at 9.4 T in accordance with the iron content of
the samples (Fig. 4). At 1.5 T, the T2W FSE images
provided the clearest reduction in observed signal inten-
sity between labeled cells and unlabeled controls
(Fig. 4). In the rotating incubation method labeled
(0.2mg Fe/mL) group, there was 89 4% signal
reduction on T2W FSE images whereas only 60 7%
reduction in signal intensity was detected in the electro-
poration group.
There was no signiﬁcant diﬀerence between prolifer-
ation rate of the SPIO labeled BMMNCs and control
cells with either in vitro labeling method, although
seven days after the start of culturing, there was a stat-
istically signiﬁcant diﬀerence between the cells labeled
by electroporation and control cells (P< 0.001) (Fig. 4).
Discussion
In general, the main objective of all cellular MRI tech-
niques is to visualize cells reliably within the target
tissue. The current study describes a method for assess-
ing the labeling of BMMNCs both in vitro and in an
AMI model.
Here, two novel methods of direct in vitro cell label-
ing were evaluated in order to validate them for the
subsequent in vivo experiment. Previous reports
(21,26) have also demonstrated that labeling of cells
can be achieved without transfection agents by using
carboxydextran-coated SPIO particles. Furthermore,
both methods were functionally feasible, achieving
rapid 1 h labeling. In previous reports, only magneto-
electroporation has reached a clinically feasible time
margin. By increasing the contrast agent dosage, we
could further shorten the labelling time, however the
high dose of the SPIO label increases the risk of iron
oxide aggregation, a problem since the aggregates can
pass through ﬁlters and be administered into a recipi-
ent’s bloodstream potentially causing clotting in the
microvasculature. In addition, free iron aggregates
would introduce less speciﬁc imaging.
Our labeling methods exerted no signiﬁcant eﬀect on
cellular viability or proliferation rate (in vitro), which is
in accordance with previous reports (27–28).
MRI in vitro showed a clear correspondence
between the label and the relaxation rates at 9.4 T. A
similar relationship was observed between label concen-
tration and signal intensity changes at 1.5 T. Both
methods were functionally feasible and displayed
rapid labeling, but the rotating incubation method
proved to be more sensitive than electroporation
while achieving suﬃcient signal voids and thus was
chosen for in vivo experiments.
In the in vivo experiments, the standardized myocar-
dial segmentation model represented a key element for
observation, making possible a retrospective radiologi-
cal-histological comparison and the segregation of ter-
ritories vascularized by the CCA and other coronary
arteries (24). Hemorrhage is known to have inﬂuence
on signal decay; however, in histology we did not
observe signiﬁcant hemorrhage and ferritin and hemo-
siderin concentrations were low. Therefore, the amount
of hemorrhage was concluded not to have had a signiﬁ-
cant impact on signal intensity and thus the signal
decrease was concluded mainly to be caused by the
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label and not by the hemorrhage. A clear radiological–
pathological correlation of cell visualization in both
visual and qualitative analyses was observed with
100% sensitivity and speciﬁcity. Furthermore, the
qualitative cell-count grading comparison displayed
an excellent correlation. In our view, these ﬁndings
reﬂect the extreme sensitivity of MRI to detect the
label and are also in line with previous works with
larger animals, where the SPIO-labeled cells were eﬃ-
ciently detected with in vivo MRI (18,19). Our study
augments the methodology by introducing a validation
protocol for labeling the cells from the in vitro stage to
in vivo implementation.
The quantitative MRI analysis appears to be as eﬃ-
cient as a qualitative analysis in detecting the labeled
cells; however, we did not detect any signiﬁcant correl-
ation between the relative signal change in MRI and the
label area ratio in histology. We think this discrepancy
is likely caused by the diﬃculty of combining the volu-
metric datasets originating from MRI to the 2D data of
histology. It is noteworthy that histological analyses,
both qualitative and quantitative, proved valuable in
conﬁrming the presence of labeled cells in tissue.
Further studies will be needed to assess the possible
use of volumetric histological data for accurately qual-
ifying tissue label content. The extent of the altered
ejection fraction was similar between the study animals,
suggesting that our MI model was well standardized.
This further strengthens the signiﬁcance of the high
spatial correlation of the labeled cells in histology and
in MRI morphology. An overall high spatial corres-
pondence was observed between the intramural area
of infarction in the in vivo DE and perfusion
images, the ex vivo T2W short axis images, and in
the gross pathology. In addition to functional changes,
DE images revealed persistent hypoenhancement
within the hyperenhanced regions, suggesting the pres-
ence of persistent microvascular obstruction (PMO) in
the area of AMI. PMO has been associated with an
increased risk of further cardiac events, poor long-
term prognosis, post-infarct complications (29,30),
and the extent of PMO has been related to the dur-
ation of coronary occlusion (31). Here, the signal loss
in DE images was impaired due to the susceptibility
artifacts generated by the label, and therefore the
extent to which PMO was indeed present remains
uncertain. Similar diﬃculties were also observed in the
analysis of the perfusion images. The confounding
eﬀects of label are due to the iron oxide particles,
which are known to cause changes in the tissue signal
similar with naturally occurring endogenous processes
such as hemorrhage and macrophage intake of iron
(29,32–35). The challenge of MRI quantiﬁcation of
the SPIO label and corresponding number of labeled
cells remains as MRI cannot detect cells directly.
The goal of cellular therapy in AMI is to replace
the apoptotic myocytes and to modulate inﬂammatory
processes. Our data revealed changes in both local-
ization and morphology, which we interpret as a sign
of active migration of BMMNCs and their adherence
to endothelial cells and myocytes, ﬁndings in line with
our previous study, where a cardiac explant culture
model was used to study the behavior of injected
MSCs and the SPIO label did not inﬂuence cellular
migration (36).
The major limitations of the present study were the
small number of animals and the lack of longitudinal
temporal tracking of cells. However, its purpose was to
establish the correspondence between imaging and hist-
ology in an acute setting and a longitudinal study
would not have provided additional information. The
variability of methods used can be viewed as a short-
coming but this was inevitable due to the heterogeneity
of imaging protocols generally used to perform a clin-
ical cardiac MRI. Importantly, we were able to perform
label quantiﬁcation using both MRI data and histology
samples. The lack of control animals in this study is a
weakness. However, the cell distribution and migration
are likely to diﬀer because of hemorrhaging, edema,
and hypo-perfusion and thus control animals without
AMI would not be appropriate comparisons as the goal
of the work was to evaluate the distribution and migra-
tion of cells in the acute phase of AMI.
In conclusion, SPIO labeling for imaging purposes is
possible by novel yet simple methods—the rotating
incubation method and electroporation. MRI can
achieve both accurate detection and quantiﬁcation of
SPIO labeled cells in a large-animal AMI model.
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